COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 1959: Articles 19581-19590  | Next

Large parallel screen of saliva and nasopharyngeal swabs in a test center setting proofs utility of saliva as alternate specimen for SARS-CoV-2 detection by RT-PCR
Huber, M., Schreiber, P. W., Scheier, T., Audige, A., Buonomano, R., Rudiger, A., Braun, D. L., Eich, G., Keller, D., Hasse, B., Berger, C., Manrique, A., Guenthard, H. F., Boeni, J., Trkola, A.
10.1101/2020.12.01.20241778 — Posted: 2020-12-03
A Novel Model for Simulating COVID-19 Dynamics Through Layered Infection States that Integrate Concepts from Epidemiology, Biophysics and Medicine: SEI3R2S-Nrec
Winters, J. M.
10.1101/2020.12.01.20242263 — Posted: 2020-12-03
How effective are face coverings in reducing transmission of COVID-19?
Robinson, J. F., Rios de Anda, I., Moore, F. J., Gregson, F. K. A., Reid, J. P., Husain, L., Sear, R. P., Royall, C. P.
10.1101/2020.12.01.20241992 — Posted: 2020-12-03
Impact of social distancing regulations and epidemic risk perception on social contact and SARS-CoV-2 transmission potential in rural South Africa: analysis of repeated cross-sectional surveys
McCreesh, N., Dlamini, V., Edwards, A., Olivier, S., Dayi, N., Dikgale, K., Nxumalo, S., Dreyer, J., Baisley, K., Siedner, M., White, R. G., Herbst, K., Grant, A., Harling, G.
10.1101/2020.12.01.20241877 — Posted: 2020-12-03
Associations between vaping and Covid-19: cross-sectional findings from the HEBECO study
Kale, D., Herbec, A., Perski, O., Jackson, S. E., Brown, J., Shahab, L.
10.1101/2020.12.01.20241760 — Posted: 2020-12-03
Variants in SARS-CoV-2 Associated with Mild or Severe Outcome
Voss, J. D., Skarzynski, M., McAuley, E. M., Maier, E. J., Gibbons, T. F., Fries, A. C., Chapleau, R. R.
10.1101/2020.12.01.20242149 — Posted: 2020-12-03 Discussion: Offsite
The COVID-19 herd immunity threshold is not low: A re-analysis of European data from spring of 2020
Fox, S. J., Potu, P., Srinivasan, R., Lachmann, M., Meyers, L. A.
10.1101/2020.12.01.20242289 — Posted: 2020-12-03
Prediction of Covid-19 spreading and optimal coordination of counter-measures: From microscopic to macroscopic models to Pareto fronts
Wulkow, H., Conrad, T., Djurdjevac Conrad, N., Mueller, S. A., Nagel, K., Schuette, C.
10.1101/2020.12.01.20241885 — Posted: 2020-12-03
Implications of delayed reopening in controlling the COVID-19 surge in Southern and West-Central USA
Abhijit Dandekar, R., Wang, E., Barbastathis, G., Rackauckas, C.
10.1101/2020.12.01.20242172 — Posted: 2020-12-03
Extrapolation of United Kingdom Pillar 2 Care home Covid-19 test data to ascertain effectiveness of lateral flow testing in low prevalence settings
Richter, A., Best, A., Mirza, J., Percival, B., Mayhew, M., Megram, O., Ashford, F., White, T., Moles-Garcia, E., Plant, T., Bosworth, A., Kidd, M., McNally, A.
10.1101/2020.12.01.20237784 — Posted: 2020-12-03 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).